Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach
- 6 June 2022
- journal article
- research article
- Published by Wiley in Transfusion Medicine
- Vol. 32 (5) , 366-374
Abstract
Background and objectives: Current genotyping techniques allow typing of all relevant red cell, human leukocyte and platelet antigens in a single analysis. Even genetic markers related to donor health can be added. Implementation of this technology will affect various stakeholders within the transfusion chain. This study aims to systematically map the anticipated advantages and disadvantages of a national rollout of blood group genotyping of donors, which will affect the availability of rare donors and the implementation of an extensively typed blood transfusion policy.Materials and methods: Two focus‐group sessions were held with a wide representation of stakeholders, including representatives of donor and patient organisations. A dedicated software tool was used to collect the reflections of participants on genotyping for blood group antigens and extensive matching. Additionally, stakeholders and experts discussed various prepared propositions. All information collected was categorised.Results: From 162 statements collected, 59 statements (36%) were labelled as ‘hopes’ and 77 (48%) as ‘fears’. Twenty‐six (16%) statements remained unlabelled. The statements were divided in 18 categories under seven main themes: patient health, genotyping, privacy issues and ethical aspects, donor management, inventory management and logistics, hospital and transfusion laboratory and general aspects. The discussion on the propositions was analysed and summarised.Conclusion: Stakeholders believe that a genotyped donor pool can result in a reduction of alloimmunization and higher availability of typed blood products. There are concerns regarding logistics, costs, consent for extended typing, data sharing, privacy issues and donor management. These concerns need to be carefully addressed before further implementation.Keywords
Funding Information
- Stichting Sanquin Bloedvoorziening
This publication has 21 references indexed in Scilit:
- Guidelines for pre‐transfusion compatibility procedures in blood transfusion laboratoriesTransfusion Medicine, 2012
- High Risk of Transfusion-induced Alloimmunization of Patients with Inflammatory Bowel DiseaseThe American Journal of Medicine, 2012
- Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodiesBlood, 2009
- Red cell genotyping and the future of pretransfusion testingBlood, 2009
- Will Genotyping Replace Serology in Future Routine Blood Grouping? – Opinion 3Transfusion Medicine and Hemotherapy, 2009
- Will Genotyping Replace Serology in Future Routine Blood Grouping? – Opinion 1Transfusion Medicine and Hemotherapy, 2009
- Stochastic modeling of human RBC alloimmunization: evidence for a distinct population of immunologic respondersBlood, 2008
- Cost‐efficient sequence‐specific priming–polymerase chain reaction screening for blood donors with rare phenotypesTransfusion, 2008
- The BloodGen project: toward mass‐scale comprehensive genotyping of blood donors in the European Union and beyondTransfusion, 2007
- Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high‐throughput DNA analysisTransfusion, 2007